NCT06764576 Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
| NCT ID | NCT06764576 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Mycobacterial Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 13,000 participants |
| Start Date | 2021-12-19 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 13,000 participants in total. It began in 2021-12-19 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the last 30 years, tuberculosis (TB) has re-emerged in industrialised countries as a public health, with a decrease in incidence among the resident population and an increase in the burden of immigrants. Therefore, it becomes a priority to implement an effective TB control that relies on both rapid and reliable identification of active infections, with a adequate treatment and surveillance of resistance, but also on the identification of latent tuberculosis infections (ITBL) in populations at higher risk of progression to the active disease, representing a source of infection for the community.
Eligibility Criteria
Inclusion Criteria: * age of 18 years or more, * clinical/radiological suspicion of TB or non-tubercular mycobacteriosis or ITBL for which sent to the Microbiology laboratory at least one biological sample for the mycobacteria and/or a blood sample for the IGRA test; * Obtaining informed consent. Exclusion Criteria: * None
Contact & Investigator
Paola Dal Monte, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06764576 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mycobacterial Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06764576 currently recruiting?
Yes, NCT06764576 is actively recruiting participants. Contact the research team at paola.dalmonte@unibo.it for enrollment information.
Where is the NCT06764576 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06764576 clinical trial?
NCT06764576 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Paola Dal Monte, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 13,000 participants.